| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 06, 2026 |
GH Research PLC
GHRS
|
BUY |
$32.00
Est. +109%
|
$15.34 | $25.88 |
Pending
|
$21.12
+37.7%
|
| Jan 12, 2026 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$235.00
Est. +46%
|
$161.13 | $243.32 |
Target Met
|
$230.56
+43.1%
|
| Jan 05, 2026 |
Praxis Precision Medicines Inc
PRAX
|
BUY |
$460.00
Est. +61%
|
$286.40 | $366.52 |
Pending
|
$266.58
-6.9%
|
| Jan 05, 2026 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$225.00
Est. +26%
|
$178.69 | $257.93 |
Target Met
|
$255.17
+42.8%
|
| Dec 05, 2025 |
Praxis Precision Medicines Inc
PRAX
|
BUY |
$304.00
Est. +19%
|
$255.76 | $366.52 |
Target Met
|
$266.58
+4.2%
|
| Oct 29, 2025 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$184.00
Est. +25%
|
$147.38 | $169.57 |
Pending
|
$159.76
+8.4%
|
| Oct 13, 2025 |
Mind Medicine Inc
MNMD
|
BUY |
$28.00
Est. +137%
|
$11.81 | $21.10 |
Pending
|
$20.69
+75.2%
|
| Oct 13, 2025 |
Definium Therapeutics, Inc.
DFTX
|
BUY |
$28.00
Est. +137%
|
$11.81 | $25.16 |
Pending
|
$24.75
+109.6%
|
| May 19, 2025 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$30.00
Est. +36%
|
$21.98 | $28.35 |
Miss
|
$21.09
-4.0%
|
| Feb 12, 2025 |
Biogen Inc
BIIB
|
BUY |
$270.00
Est. +102%
|
$133.43 | $202.41 |
Miss
|
$200.05
+49.9%
|
| Jan 09, 2025 |
Avadel Pharmaceuticals plc
AVDL
|
BUY |
$19.00
Est. +75%
|
$10.86 | $23.57 |
Target Met
|
$21.64
+99.3%
|
| Oct 31, 2024 |
Blueprint Medicines Corp
BPMC
|
BUY |
$135.00
Est. +51%
|
$89.24 | $129.65 |
Miss
|
$129.46
+45.1%
|
| Sep 04, 2024 |
Praxis Precision Medicines Inc
PRAX
|
BUY |
$151.00
Est. +416%
|
$29.25 | $91.83 |
Miss
|
$266.58
+811.4%
|
| Aug 14, 2024 |
Praxis Precision Medicines Inc
PRAX
|
BUY |
$145.00
Est. +464%
|
$25.73 | $91.83 |
Miss
|
$266.58
+936.1%
|
| Aug 08, 2024 |
Revolution Medicines Inc
RVMD
|
BUY |
$61.00
Est. +43%
|
$42.73 | $62.40 |
Precision Hit (±3%)
|
$153.87
+260.1%
|
| Aug 05, 2024 |
Merus N.V
MRUS
|
BUY |
$85.00
Est. +70%
|
$50.14 | $67.58 |
Miss
|
$90.00
+79.5%
|
| Jul 22, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$100.00
Est. +34%
|
$74.86 | $131.98 |
Target Met
|
$131.87
+76.2%
|
| Jul 22, 2024 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$23.00
Est. +104%
|
$11.28 | $17.19 |
Miss
|
$1.78
-84.2%
|
| May 01, 2024 |
Harmony Biosciences Holdings Inc
HRMY
|
BUY |
$52.00
Est. +71%
|
$30.37 | $41.61 |
Miss
|
$34.46
+13.5%
|
| Apr 12, 2024 |
Revolution Medicines Inc
RVMD
|
BUY |
$46.00
Est. +23%
|
$37.41 | $62.40 |
Target Met
|
$153.87
+311.3%
|
| Apr 05, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$82.00
Est. +22%
|
$67.21 | $131.98 |
Target Met
|
$131.87
+96.2%
|
| Mar 12, 2024 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$32.00
Est. +60%
|
$19.98 | $20.67 |
Miss
|
$21.09
+5.6%
|
| Jan 24, 2024 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$37.00
Est. +36%
|
$27.19 | $19.44 |
Miss
|
$21.09
-22.4%
|
| Sep 28, 2022 |
Biogen Inc
BIIB
|
BUY |
$250.00
Est. +26%
|
$197.79 | - | - |
$200.05
+1.1%
|
| Apr 11, 2022 |
Biogen Inc
BIIB
|
BUY |
$262.00
Est. +24%
|
$210.62 | - | - |
$200.05
-5.0%
|
| Mar 03, 2022 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$215.00
Est. +41%
|
$152.90 | - | - |
$230.56
+50.8%
|
| Feb 13, 2022 |
Biogen Inc
BIIB
|
BUY |
$290.00
Est. +35%
|
$214.59 | - | - |
$200.05
-6.8%
|
| Jan 30, 2022 |
Biogen Inc
BIIB
|
BUY |
$292.00
Est. +30%
|
$225.21 | - | - |
$200.05
-11.2%
|